Asensus Surgical Inc (ASXC)

[longtermgems]

Alf-x is big but so is davinci. It's laparoscopic motion means much shorter learning curve compared to robotic surgery. Up front cost for system is similar price to da Vinci, but per procedure economics for alf-x is much more appealing to hospitals than da Vinci.

TRXC is backed by a number of prominent VCs and institutions, and has a top notch management team that knows how to raise money and execute on building out an actual business and creating jobs.

Alf-x has been actively marketed on the market for one year, has one sale. Hasn't been marketed for sale until late 2015. Capital sales cycle for these machines is average 1-2 years, so expect sales to start building up going forward.

Meanwhile your other choice for investing in a robotic surgery start up is garbage Canadian company that has no money, dilutes like crazy, has crappy management team, and is more than two years away from getting their robot approved and on the market. SAD!!!